$RGBP
Regen BioPharma Inc Stock $rgbp

$rgbp Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000160706222000694 Filed on November 15, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2022
Revenue	$31.64K	$59.37K	$125.5K
YoY Change	-46.44%	-0.57%	-26.68%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$427.4K	$92.88K	$299.7K
YoY Change	758.45%	-43.96%	-10.6%
% of Gross Profit
Research & Development	$95.51K	$64.27K	$158.1K
YoY Change	-17.44%	208.84%	330.89%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$95.51K	$157.1K	$158.1K
YoY Change	-42.28%	-15.76%	-57.49%
Operating Profit	-$463.9K		-$339.6K
YoY Change	335.88%		69.15%
Interest Expense	$17.36K	$65.25K	$138.7K
YoY Change	-99.38%	-113.53%	-102.4%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$45.50K	-$282.8K
YoY Change	-100.0%
Pretax Income	$1.636M	-$78.03K	$2.444M
YoY Change	-38.16%	-94.36%	-136.12%
Income Tax
% Of Pretax Income
Net Earnings	$1.636M	-$78.03K	$2.444M
YoY Change	-38.16%	-94.36%	-136.12%
Net Earnings / Revenue	5169.82%	-131.42%	1946.77%
Basic Earnings Per Share	$0.45		$0.71
Diluted Earnings Per Share	$0.43	-$17.60	$519.50
COMMON SHARES
Basic Shares Outstanding	5.032B shares	4.970B shares	4.704B shares
Diluted Shares Outstanding	3.361M shares		3.136M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$40.74K	$51.20K	$51.20K
YoY Change	-88.47%	-92.96%	-92.96%
Cash & Equivalents	$40.74K	$51.20K
Short-Term Investments
Other Short-Term Assets	$19.09K	$30.95K	$30.95K
YoY Change	-53.77%	-35.71%	-35.71%
Inventory
Prepaid Expenses	$14.09K	$20.95K
Receivables	$131.7K	$254.3K	$254.3K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$191.5K	$336.4K	$336.4K
YoY Change	-70.13%	-66.16%	-66.16%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$222.6K	$222.6K	$222.6K
YoY Change	136.59%	2.11%	2.11%
Other Assets
YoY Change
Total Long-Term Assets	$222.6K	$222.6K	$222.6K
YoY Change	136.59%	2.11%	2.11%
TOTAL ASSETS
Total Short-Term Assets	$191.5K	$336.4K	$336.4K
Total Long-Term Assets	$222.6K	$222.6K	$222.6K
Total Assets	$414.1K	$559.0K	$559.0K
YoY Change	-43.68%	-53.88%	-53.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$31.04K	$28.80K	$28.80K
YoY Change	-3.87%	-68.52%	-68.52%
Accrued Expenses	$1.614M	$2.002M	$2.002M
YoY Change	-18.26%	-11.69%	-11.69%
Deferred Revenue
YoY Change
Short-Term Debt	$1.710K	$1.710K	$1.710K
YoY Change	-99.88%	-99.88%	-99.88%
Long-Term Debt Due	$509.9K	$1.272M	$1.272M
YoY Change	-59.92%	-40.9%	-40.9%
Total Short-Term Liabilities	$5.299M	$8.595M	$8.595M
YoY Change	-49.49%	-41.52%	-41.52%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.299M	$8.595M	$8.595M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$5.299M	$8.595M	$8.595M
YoY Change	-49.49%	-41.52%	-41.52%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.27M	-$20.91M
YoY Change		-10.47%
Common Stock	$504.8K	$503.2K
YoY Change		15.65%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$4.885M	-$8.036M	-$8.036M
YoY Change
Total Liabilities & Shareholders Equity	$414.1K	$559.0K	$559.0K
YoY Change	-43.68%	-53.88%	-53.88%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2022
OPERATING ACTIVITIES
Net Income	$1.636M	-$78.03K	$2.444M
YoY Change	-38.16%	-94.36%	-136.12%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$10.46K	-$85.29K	$606.9K
YoY Change	-96.25%	-92.01%	-153.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$25.00K	$25.00K
YoY Change		-87.18%	-94.95%
Cash From Investing Activities	$0.00	$25.00K	$25.00K
YoY Change		-87.18%	-94.95%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	500.0	-$94.04K
YoY Change	-100.0%	-99.96%	-106.9%
NET CHANGE
Cash From Operating Activities	-$10.46K	-85.29K	$606.9K
Cash From Investing Activities	$0.00	25.00K	$25.00K
Cash From Financing Activities	$0.00	500.0	-$94.04K
Net Change In Cash	-$10.46K	-59.79K	-$676.0K
YoY Change	-97.2%	-111.09%	-192.96%
FREE CASH FLOW
Cash From Operating Activities	-$10.46K	-$85.29K	$606.9K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	us-gaap	Cash Cash	727162	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	254273	usd
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	213192	usd
CY2022Q3	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	0	usd
CY2022	dei	Local Phone Number LocalPhoneNumber	722 5505
CY2022Q3	us-gaap	Cash Cash	51204	usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001589150
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue		usd
CY2021	us-gaap	Interest Paid InterestPaid		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	333-191725
CY2022	dei	Entity Registrant Name EntityRegistrantName	REGEN BIOPHARMA, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-5192997
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	4700 Spring Street
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 304
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	La Mesa
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91942
CY2022	dei	City Area Code CityAreaCode	619
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	No
CY2022Q4	dei	Entity Public Float EntityPublicFloat	27918610	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5031517324	shares
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2021Q3	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	5396	usd
CY2022Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	0	usd
CY2021Q3	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	230	usd
CY2022Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	20945	usd
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	48144	usd
CY2022Q3	us-gaap	Prepaid Rent PrepaidRent	10000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	336422	usd
CY2021Q3	us-gaap	Assets Current AssetsCurrent	994124	usd
CY2022Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	0	usd
CY2021Q3	us-gaap	Available For Sale Securities AvailableForSaleSecurities	198006	usd
CY2022Q3	RGBP	Investment Securities Related Party InvestmentSecuritiesRelatedParty	222580	usd
CY2021Q3	RGBP	Investment Securities Related Party InvestmentSecuritiesRelatedParty	19969	usd
CY2022Q3	us-gaap	Other Assets OtherAssets	222580	usd
CY2021Q3	us-gaap	Other Assets OtherAssets	217975	usd
CY2022Q3	us-gaap	Assets Assets	559002	usd
CY2021Q3	us-gaap	Assets Assets	1212099	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	28799	usd
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	91498	usd
CY2022Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	710	usd
CY2021Q3	us-gaap	Notes And Loans Payable NotesAndLoansPayable	1429179	usd
CY2022Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4241	usd
CY2021Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	4241	usd
CY2022Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	689785	usd
CY2021Q3	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	954861	usd
CY2022Q3	RGBP	Accrued Rent AccruedRent	0	usd
CY2021Q3	RGBP	Accrued Rent AccruedRent	0	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1266679	usd
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1266679	usd
CY2022Q3	RGBP	Other Accrued Expenses OtherAccruedExpenses	41423	usd
CY2021Q3	RGBP	Other Accrued Expenses OtherAccruedExpenses	41423	usd
CY2022Q3	us-gaap	Bank Overdrafts BankOverdrafts	1000	usd
CY2021Q3	us-gaap	Bank Overdrafts BankOverdrafts	1000	usd
CY2022Q3	RGBP	Due To Investor DueToInvestor	20000	usd
CY2021Q3	RGBP	Due To Investor DueToInvestor	20000	usd
CY2022Q3	RGBP	Unearned Income UnearnedIncome	1718290	usd
CY2021Q3	RGBP	Unearned Income UnearnedIncome	1843806	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	3551793	usd
CY2021Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	6892477	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	1262340	usd
CY2021Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2131311	usd
CY2022Q3	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount	10000	usd
CY2021Q3	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscount	21500	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8595061	usd
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	14697976	usd
CY2021Q3	RGBP	Convertible Notes Payable Related Parties Less Unamortized Discount Noncurrent ConvertibleNotesPayableRelatedPartiesLessUnamortizedDiscountNoncurrent	0	usd
CY2022Q3	us-gaap	Liabilities Liabilities	8595061	usd
CY2021Q3	us-gaap	Liabilities Liabilities	14697976	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5800000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5031517324	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5031517324	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	4800000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4350554514	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4350554514	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	503150	usd
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	435054	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	11581499	usd
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8644037	usd
CY2022Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	736326	usd
CY2021Q3	us-gaap	Other Additional Capital OtherAdditionalCapital	736326	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20905369	usd
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23348900	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-8036059	usd
CY2021Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-13485877	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	559002	usd
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1212099	usd
CY2022	us-gaap	Revenues Revenues	125517	usd
CY2021	us-gaap	Revenues Revenues	61194	usd
CY2022	RGBP	Revenues Related Party RevenuesRelatedParty	110000	usd
CY2021	RGBP	Revenues Related Party RevenuesRelatedParty	110000	usd
CY2022	RGBP	Total Revenues TotalRevenues	235517	usd
CY2021	RGBP	Total Revenues TotalRevenues	171194	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	158138	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	36704	usd
CY2022	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	117250	usd
CY2021	RGBP	Research And Development Related Party ResearchAndDevelopmentRelatedParty	0	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	28055	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	119495	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	221679	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	190765	usd
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	50000	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	25000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	575122	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	371964	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-339605	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-200771	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	455	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	230	usd
CY2022	us-gaap	Interest Expense InterestExpense	138720	usd
CY2021	us-gaap	Interest Expense InterestExpense	316013	usd
CY2022	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-71067	usd
CY2021	RGBP	Interest Expense Attributable To Amortization Of Discount InterestExpenseAttributableToAmortizationOfDiscount	-51015	usd
CY2022	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	300000	usd
CY2021	us-gaap	Income Tax Examination Penalties Expense IncomeTaxExaminationPenaltiesExpense	-0	usd
CY2022	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	31433	usd
CY2021	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	-632094	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-1828	usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-524960	usd
CY2022	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	62700	usd
CY2021	RGBP	Gain Loss On Derecognition Of Accounts Payable GainLossOnDerecognitionOfAccountsPayable	0	usd
CY2022	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3340683	usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-4264975	usd
CY2022	RGBP	Financing Fees FinancingFees	-45500	usd
CY2021	RGBP	Financing Fees FinancingFees	0	usd
CY2022	RGBP	Legal Settlement LegalSettlement	0	usd
CY2021	RGBP	Legal Settlement LegalSettlement	-800000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-95019	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	24365	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2783136	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6564462	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2443531	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-6765233	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2227034	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6765233	usd
CY2022	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	0.0005
CY2021	RGBP	Basic And Fully Diluted Earnings Loss Per Share BasicAndFullyDilutedEarningsLossPerShare	-0.00225
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4703768705	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3011544584	shares
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-7334998	usd
CY2020Q4	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	3752	usd
CY2020Q4	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	1452	usd
CY2020Q4	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	3900	usd
CY2020Q4	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	1555	usd
CY2020Q4	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	7300	usd
CY2020Q4	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	3142	usd
CY2020Q4	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	429	usd
CY2020Q4	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	236	usd
CY2020Q4	RGBP	Shares Issued For Fees Value SharesIssuedForFeesValue	159	usd
CY2020Q4	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	4030	usd
CY2020Q4	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	1700	usd
CY2020Q4	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	8200	usd
CY2020Q4	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	1700	usd
CY2020Q4	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	13000	usd
CY2020Q4	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	8046	usd
CY2020Q4	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	16000	usd
CY2020Q4	RGBP	Shares Issued For Interest Value7 SharesIssuedForInterestValue7	3250	usd
CY2020Q4	RGBP	Shares Issued For Debt8 Amount SharesIssuedForDebt8Amount	5330	usd
CY2020Q4	RGBP	Shares Issued For Interest Value8 SharesIssuedForInterestValue8	2329	usd
CY2020Q4	RGBP	Additions To Contributed Capital AdditionsToContributedCapital	1865	usd
CY2020Q4	us-gaap	Profit Loss ProfitLoss	1666367	usd
CY2021Q1	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	5154	usd
CY2021Q1	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	4400	usd
CY2021Q1	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	30000	usd
CY2021Q1	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	4758	usd
CY2021Q1	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	5260	usd
CY2021Q1	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	2492	usd
CY2021Q1	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	3357	usd
CY2021Q1	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	441	usd
CY2021Q1	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	1000	usd
CY2021Q1	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	5750	usd
CY2021Q1	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	3415	usd
CY2021Q1	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	84	usd
CY2021Q1	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	1925	usd
CY2021Q1	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	74	usd
CY2021Q1	RGBP	Additions To Contributed Capital AdditionsToContributedCapital	250	usd
CY2021Q1	us-gaap	Profit Loss ProfitLoss	442183	usd
CY2021Q2	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	3111	usd
CY2021Q2	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	49	usd
CY2021Q2	RGBP	Preferred Shares Issued For Services PreferredSharesIssuedForServices	1	usd
CY2021Q2	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	19000	usd
CY2021Q2	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	4736	usd
CY2021Q2	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	3510	usd
CY2021Q2	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	1508	usd
CY2021Q2	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	6340	usd
CY2021Q2	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	3179	usd
CY2021Q2	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	2288	usd
CY2021Q2	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	680	usd
CY2021Q2	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	4238	usd
CY2021Q2	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	17	usd
CY2021Q2	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	47000	usd
CY2021Q2	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	8189	usd
CY2021Q2	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	7655	usd
CY2021Q2	RGBP	Shares Issued For Interest Value7 SharesIssuedForInterestValue7	2264	usd
CY2021Q2	RGBP	Shares Issued For Debt8 Amount SharesIssuedForDebt8Amount	22000	usd
CY2021Q2	RGBP	Shares Issued For Interest Value8 SharesIssuedForInterestValue8	3905	usd
CY2021Q2	RGBP	Shares Issued For Debt9 Amount SharesIssuedForDebt9Amount	1416	usd
CY2021Q2	RGBP	Shares Issued For Interest Value9 SharesIssuedForInterestValue9	729	usd
CY2021Q2	RGBP	Shares Issued For Debt10 Amount SharesIssuedForDebt10Amount	1187	usd
CY2021Q2	RGBP	Shares Issued For Interest Value10 SharesIssuedForInterestValue10	616	usd
CY2021Q2	RGBP	Shares Issued For Debt11 Amount SharesIssuedForDebt11Amount	2026	usd
CY2021Q2	RGBP	Contributed Capital ContributedCapital	2500	usd
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-7489115	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-12411685	usd
CY2021Q3	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	500	usd
CY2021Q3	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	19344	usd
CY2021Q3	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	10000	usd
CY2021Q3	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	10000	usd
CY2021Q3	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	10000	usd
CY2021Q3	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	35000	usd
CY2021Q3	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	12993	usd
CY2021Q3	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	4200	usd
CY2021Q3	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	50000	usd
CY2021Q3	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	24876	usd
CY2021Q3	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	50000	usd
CY2021Q3	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	24780	usd
CY2021Q3	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	40000	usd
CY2021Q3	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	18783	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-1384668	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-13485877	usd
CY2021Q4	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	26662	usd
CY2021Q4	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	38837	usd
CY2021Q4	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value2 SharesIssuedForInterestValue2	19603	usd
CY2021Q4	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value3 SharesIssuedForInterestValue3	18575	usd
CY2021Q4	RGBP	Shares Issued For Interest Value4 SharesIssuedForInterestValue4	75000	usd
CY2021Q4	RGBP	Shares Issued For Debt4 Amount SharesIssuedForDebt4Amount	32075	usd
CY2021Q4	RGBP	Shares Issued For Interest Value5 SharesIssuedForInterestValue5	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value6 SharesIssuedForInterestValue6	10356	usd
CY2021Q4	RGBP	Shares Issued For Debt5 Amount SharesIssuedForDebt5Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value7 SharesIssuedForInterestValue7	8883	usd
CY2021Q4	RGBP	Shares Issued For Debt6 Amount SharesIssuedForDebt6Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value8 SharesIssuedForInterestValue8	23369	usd
CY2021Q4	RGBP	Shares Issued For Debt7 Amount SharesIssuedForDebt7Amount	100000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value9 SharesIssuedForInterestValue9	39808	usd
CY2021Q4	RGBP	Shares Issued For Debt8 Amount SharesIssuedForDebt8Amount	40000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value10 SharesIssuedForInterestValue10	14192	usd
CY2021Q4	RGBP	Shares Issued For Debt9 Amount SharesIssuedForDebt9Amount	50000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value11 SharesIssuedForInterestValue11	19012	usd
CY2021Q4	RGBP	Shares Issued For Debt10 Amount SharesIssuedForDebt10Amount	10964	usd
CY2021Q4	RGBP	Shares Issued For Debt11 Amount SharesIssuedForDebt11Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value12 SharesIssuedForInterestValue12	11527	usd
CY2021Q4	RGBP	Shares Issued For Debt12 Amount SharesIssuedForDebt12Amount	60000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value13 SharesIssuedForInterestValue13	25440	usd
CY2021Q4	RGBP	Shares Issued For Debt13 Amount SharesIssuedForDebt13Amount	25000	usd
CY2021Q4	RGBP	Shares Issued For Interest Value14 SharesIssuedForInterestValue14	10625	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	2644980	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-9755969	usd
CY2022Q1	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	48420	usd
CY2022Q1	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	39708	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-67081589	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-76749430	usd
CY2022Q2	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	218617	usd
CY2022Q2	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	1701	usd
CY2022Q2	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	550161	usd
CY2022Q2	RGBP	Shares Issued For Interest Value1 SharesIssuedForInterestValue1	1500	usd
CY2022Q2	RGBP	Shares Issued For Debt2 Amount SharesIssuedForDebt2Amount	334800	usd
CY2022Q2	RGBP	Shares Issued For Debt3 Amount SharesIssuedForDebt3Amount	334800	usd
CY2022Q2	us-gaap	Profit Loss ProfitLoss	66958167	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-8349684	usd
CY2022Q3	RGBP	Shares Issued For Debt Amount SharesIssuedForDebtAmount	132650	usd
CY2022Q3	RGBP	Shares Issued For Interest Value SharesIssuedForInterestValue	32950	usd
CY2022Q3	RGBP	Shares Issued For Debt1 Amount SharesIssuedForDebt1Amount	180552	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	45500	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-78027	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-8036059	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2443531	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-6765233	usd
CY2022	RGBP	Common Stock Issued For Expenses CommonStockIssuedForExpenses	-45500	usd
CY2021	RGBP	Common Stock Issued For Expenses CommonStockIssuedForExpenses	-159	usd
CY2022	RGBP	Preferred Stock Issued As Compensation PreferredStockIssuedAsCompensation	-0	usd
CY2021	RGBP	Preferred Stock Issued As Compensation PreferredStockIssuedAsCompensation	-1	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	71067	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	51015	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-62705	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-18988	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	41082	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	109999	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	109747	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	369825	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-17199	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	48146	usd
CY2022	RGBP	Increase Decrease In Contributed Capital IncreaseDecreaseInContributedCapital	0	usd
CY2021	RGBP	Increase Decrease In Contributed Capital IncreaseDecreaseInContributedCapital	4615	usd
CY2022	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-3340683	usd
CY2021	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	4264974	usd
CY2022	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	-125517	usd
CY2021	us-gaap	Increase Decrease In Unearned Premiums IncreaseDecreaseInUnearnedPremiums	1843806	usd
CY2022	RGBP	Increase Decrease In Penalties IncreaseDecreaseInPenalties	300000	usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-5396	usd
CY2021	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	5396	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-230	usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	230	usd
CY2022	RGBP	Securities Accepted As Compensation SecuritiesAcceptedAsCompensation	-0	usd
CY2021	RGBP	Securities Accepted As Compensation SecuritiesAcceptedAsCompensation	1850000	usd
CY2021	RGBP	Gain Loss On Forgiveness Of Debt GainLossOnForgivenessOfDebt	24364	usd
CY2022	RGBP	Increase Decrease In Loss On Sale Of Investment Securities IncreaseDecreaseInLossOnSaleOfInvestmentSecurities	-1828	usd
CY2021	RGBP	Increase Decrease In Loss On Sale Of Investment Securities IncreaseDecreaseInLossOnSaleOfInvestmentSecurities	-524930	usd
CY2022	RGBP	Unrealized Lossgain On Investment Securities UnrealizedLossgainOnInvestmentSecurities	31433	usd
CY2021	RGBP	Unrealized Lossgain On Investment Securities UnrealizedLossgainOnInvestmentSecurities	-632094	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	606921	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1130938	usd
CY2022	RGBP	Increasedecrease In Sale Of Investment Securities IncreasedecreaseInSaleOfInvestmentSecurities	-25000	usd
CY2021	RGBP	Increasedecrease In Sale Of Investment Securities IncreasedecreaseInSaleOfInvestmentSecurities	-495000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	25000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	495000	usd
CY2022	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	499	usd
CY2021	us-gaap	Increase Decrease In Notes Payable Current IncreaseDecreaseInNotesPayableCurrent	1363100	usd
CY2022	RGBP	Increase Decrease In Convertible Notes Payable IncreaseDecreaseInConvertibleNotesPayable	-94535	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-94036	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1363100	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-675957	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	727162	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	727162	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	51204	usd
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	727162	usd
CY2022	RGBP	Common Shares Issued For Debt CommonSharesIssuedForDebt	2510964	usd
CY2021	RGBP	Common Shares Issued For Debt CommonSharesIssuedForDebt	278423	usd
CY2022	RGBP	Preferred Shares Issued For Debt PreferredSharesIssuedForDebt	75000	usd
CY2021	RGBP	Preferred Shares Issued For Debt PreferredSharesIssuedForDebt	153000	usd
CY2022	us-gaap	Interest Paid InterestPaid	27473	usd
CY2022	RGBP	Common Shares Issued For Interest CommonSharesIssuedForInterest	342329	usd
CY2021	RGBP	Common Shares Issued For Interest CommonSharesIssuedForInterest	101929	usd
CY2022	RGBP	Preferred Shares Issued For Interest PreferredSharesIssuedForInterest	33994	usd
CY2021	RGBP	Preferred Shares Issued For Interest PreferredSharesIssuedForInterest	76485	usd
CY2022Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	4390127	usd
CY2022Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0389	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	8.6881	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	1	pure
CY2022	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	0	usd
CY2022Q3	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4390127	usd
	RGBP	Net Income Loss Since Inception NetIncomeLossSinceInception	20905369	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	710	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	5800000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5031517324	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5031517324	shares
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	800000000	shares
CY2022Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4390127	usd
CY2022Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	-0	usd
CY2021Q3	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	4390127	usd
CY2021Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	20905369	usd

Files In Submission

Name	View Source	Status
0001607062-22-000694-index-headers.html	Edgar Link	pending
0001607062-22-000694-index.html	Edgar Link	pending
0001607062-22-000694.txt	Edgar Link	pending
0001607062-22-000694-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
ex32_2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
rgbp-20220930.xsd	Edgar Link	pending
rgbp093022form10k.htm	Edgar Link	pending
Show.js	Edgar Link	pending
rgbp-20220930_cal.xml	Edgar Link	unprocessable
rgbp-20220930_def.xml	Edgar Link	unprocessable
rgbp-20220930_lab.xml	Edgar Link	unprocessable
rgbp-20220930_pre.xml	Edgar Link	unprocessable
rgbp093022form10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RGBP
Regen BioPharma Inc Stock $rgbp

2022 Q4 Form 10-K Financial Statement

#000160706222000694 Filed on November 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGBP Regen BioPharma Inc Stock $rgbp

2022 Q4 Form 10-K Financial Statement

#000160706222000694 Filed on November 15, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RGBP
Regen BioPharma Inc Stock $rgbp